475 related articles for article (PubMed ID: 17698157)
1. Development of a physiologically based pharmacokinetic model for bisphenol A in pregnant mice.
Kawamoto Y; Matsuyama W; Wada M; Hishikawa J; Chan MP; Nakayama A; Morisawa S
Toxicol Appl Pharmacol; 2007 Oct; 224(2):182-91. PubMed ID: 17698157
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of oral and intravenous route pharmacokinetics, plasma protein binding, and uterine tissue dose metrics of bisphenol A: a physiologically based pharmacokinetic approach.
Teeguarden JG; Waechter JM; Clewell HJ; Covington TR; Barton HA
Toxicol Sci; 2005 Jun; 85(2):823-38. PubMed ID: 15746009
[TBL] [Abstract][Full Text] [Related]
3. Toxicokinetics of bisphenol A in pregnant DA/Han rats after single i.v. application.
Moors S; Diel P; Degen GH
Arch Toxicol; 2006 Oct; 80(10):647-55. PubMed ID: 16604338
[TBL] [Abstract][Full Text] [Related]
4. Distribution of 14C-bisphenol A in pregnant and newborn mice.
Tanaka M; Kawamoto T; Matsumoto H
Dent Mater; 2010 Jun; 26(6):e181-7. PubMed ID: 20202676
[TBL] [Abstract][Full Text] [Related]
5. Disposition of low doses of 14C-bisphenol A in male, female, pregnant, fetal, and neonatal rats.
Kurebayashi H; Nagatsuka S; Nemoto H; Noguchi H; Ohno Y
Arch Toxicol; 2005 May; 79(5):243-52. PubMed ID: 15902421
[TBL] [Abstract][Full Text] [Related]
6. Physiologically based pharmacokinetics of bisphenol A.
Shin BS; Kim CH; Jun YS; Kim DH; Lee BM; Yoon CH; Park EH; Lee KC; Han SY; Park KL; Kim HS; Yoo SD
J Toxicol Environ Health A; 2004 Dec; 67(23-24):1971-85. PubMed ID: 15513896
[TBL] [Abstract][Full Text] [Related]
7. Derivation of a bisphenol A oral reference dose (RfD) and drinking-water equivalent concentration.
Willhite CC; Ball GL; McLellan CJ
J Toxicol Environ Health B Crit Rev; 2008 Feb; 11(2):69-146. PubMed ID: 18188738
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetic modeling: prediction and evaluation of route dependent dosimetry of bisphenol A in monkeys with extrapolation to humans.
Fisher JW; Twaddle NC; Vanlandingham M; Doerge DR
Toxicol Appl Pharmacol; 2011 Nov; 257(1):122-36. PubMed ID: 21920375
[TBL] [Abstract][Full Text] [Related]
9. Assessment of bisphenol A exposure in Korean pregnant women by physiologically based pharmacokinetic modeling.
Shin BS; Hwang SW; Bulitta JB; Lee JB; Yang SD; Park JS; Kwon MC; Kim DJ; Yoon HS; Yoo SD
J Toxicol Environ Health A; 2010; 73(21-22):1586-98. PubMed ID: 20954083
[TBL] [Abstract][Full Text] [Related]
10. Metabolism and pharmacokinetics of bisphenol A (BPA) and the embryo-fetal distribution of BPA and BPA-monoglucuronide in CD Sprague-Dawley rats at three gestational stages.
Domoradzki JY; Pottenger LH; Thornton CM; Hansen SC; Card TL; Markham DA; Dryzga MD; Shiotsuka RN; Waechter JM
Toxicol Sci; 2003 Nov; 76(1):21-34. PubMed ID: 12915710
[TBL] [Abstract][Full Text] [Related]
11. Estimation of placental and lactational transfer and tissue distribution of atrazine and its main metabolites in rodent dams, fetuses, and neonates with physiologically based pharmacokinetic modeling.
Lin Z; Fisher JW; Wang R; Ross MK; Filipov NM
Toxicol Appl Pharmacol; 2013 Nov; 273(1):140-58. PubMed ID: 23958493
[TBL] [Abstract][Full Text] [Related]
12. Estrogenicity of food-associated estrogenic compounds in the fetuses of female transgenic mice upon oral and IP maternal exposure.
Ter Veld MG; Zawadzka E; Rietjens IM; Murk AJ
Reprod Toxicol; 2009 Apr; 27(2):133-9. PubMed ID: 19429392
[TBL] [Abstract][Full Text] [Related]
13. PBPK models in risk assessment--A focus on chloroprene.
DeWoskin RS
Chem Biol Interact; 2007 Mar; 166(1-3):352-9. PubMed ID: 17324392
[TBL] [Abstract][Full Text] [Related]
14. Maternal and fetal exposure to bisphenol A in Korea.
Lee YJ; Ryu HY; Kim HK; Min CS; Lee JH; Kim E; Nam BH; Park JH; Jung JY; Jang DD; Park EY; Lee KH; Ma JY; Won HS; Im MW; Leem JH; Hong YC; Yoon HS
Reprod Toxicol; 2008 Aug; 25(4):413-9. PubMed ID: 18577445
[TBL] [Abstract][Full Text] [Related]
15. Concurrent determination of bisphenol A pharmacokinetics in maternal and fetal rhesus monkeys.
Patterson TA; Twaddle NC; Roegge CS; Callicott RJ; Fisher JW; Doerge DR
Toxicol Appl Pharmacol; 2013 Feb; 267(1):41-8. PubMed ID: 23261975
[TBL] [Abstract][Full Text] [Related]
16. Development of a physiologically based pharmacokinetic model describing 2-methoxyacetic acid disposition in the pregnant mouse.
Terry KK; Elswick BA; Welsch F; Conolly RB
Toxicol Appl Pharmacol; 1995 May; 132(1):103-14. PubMed ID: 7747273
[TBL] [Abstract][Full Text] [Related]
17. Development of a physiologically based pharmacokinetic model of 2-methoxyethanol and 2-methoxyacetic acid disposition in pregnant rats.
Hays SM; Elswick BA; Blumenthal GM; Welsch F; Conolly RB; Gargas ML
Toxicol Appl Pharmacol; 2000 Feb; 163(1):67-74. PubMed ID: 10662606
[TBL] [Abstract][Full Text] [Related]
18. Development of a physiologically based pharmacokinetic model for assessment of human exposure to bisphenol A.
Yang X; Doerge DR; Teeguarden JG; Fisher JW
Toxicol Appl Pharmacol; 2015 Dec; 289(3):442-56. PubMed ID: 26522835
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics of 2-methoxyethanol and 2-methoxyacetic acid in the pregnant mouse: a physiologically based mathematical model.
Clarke DO; Elswick BA; Welsch F; Conolly RB
Toxicol Appl Pharmacol; 1993 Aug; 121(2):239-52. PubMed ID: 8346541
[TBL] [Abstract][Full Text] [Related]
20. The development of a pregnancy PBPK Model for Bisphenol A and its evaluation with the available biomonitoring data.
Sharma RP; Schuhmacher M; Kumar V
Sci Total Environ; 2018 May; 624():55-68. PubMed ID: 29247905
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
